Marine Perrier

730 total citations
43 papers, 280 citations indexed

About

Marine Perrier is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Marine Perrier has authored 43 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Epidemiology and 16 papers in Neurology. Recurrent topics in Marine Perrier's work include Neuroendocrine Tumor Research Advances (20 papers), Lung Cancer Research Studies (16 papers) and Neuroblastoma Research and Treatments (15 papers). Marine Perrier is often cited by papers focused on Neuroendocrine Tumor Research Advances (20 papers), Lung Cancer Research Studies (16 papers) and Neuroblastoma Research and Treatments (15 papers). Marine Perrier collaborates with scholars based in France, Italy and United States. Marine Perrier's co-authors include Olivier Bouché, Damien Botsen, Camille Mazza, Guillaume Cadiot, Yohann Renard, Éric Bertin, Coralie Barbe, Réza Kianmanesh, Sophie Deguelte and Florian Slimano and has published in prestigious journals such as The Lancet, Cancer and Annals of Oncology.

In The Last Decade

Marine Perrier

39 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marine Perrier France 9 120 100 79 66 51 43 280
Nathan Hamilton United States 4 59 0.5× 95 0.9× 30 0.4× 14 0.2× 28 0.5× 5 410
Russell P. Sawyer United States 10 53 0.4× 84 0.8× 59 0.7× 90 1.4× 3 0.1× 22 301
George J. Francis Canada 11 117 1.0× 127 1.3× 12 0.2× 25 0.4× 13 0.3× 23 339
Tzu‐Ting Kuo Taiwan 10 75 0.6× 44 0.4× 74 0.9× 61 0.9× 2 0.0× 32 392
Gaofeng Pan China 7 24 0.2× 64 0.6× 89 1.1× 10 0.2× 30 0.6× 14 293
Sisi Dai China 11 40 0.3× 41 0.4× 18 0.2× 11 0.2× 29 0.6× 26 259
Mélissa Wills United States 9 26 0.2× 18 0.2× 46 0.6× 41 0.6× 5 0.1× 31 258
Sabrina Pigozzo Italy 8 22 0.2× 141 1.4× 57 0.7× 17 0.3× 6 0.1× 13 330
Roland Backhaus Germany 7 28 0.2× 112 1.1× 77 1.0× 110 1.7× 2 0.0× 14 308

Countries citing papers authored by Marine Perrier

Since Specialization
Citations

This map shows the geographic impact of Marine Perrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marine Perrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marine Perrier more than expected).

Fields of papers citing papers by Marine Perrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marine Perrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marine Perrier. The network helps show where Marine Perrier may publish in the future.

Co-authorship network of co-authors of Marine Perrier

This figure shows the co-authorship network connecting the top 25 collaborators of Marine Perrier. A scholar is included among the top collaborators of Marine Perrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marine Perrier. Marine Perrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perrier, Marine, Éric Bertin, Damien Botsen, et al.. (2025). Impact of low muscle mass and myosteatosis on treatment toxicity and survival outcomes in non-resectable pancreatic cancer patients treated with chemoradiotherapy. European Journal of Clinical Nutrition. 79(6). 576–586. 1 indexed citations
2.
3.
Hadoux, Julien, Pauline Afchain, Anne‐Ségolène Cottereau, et al.. (2024). Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network. Journal of Nuclear Medicine. 65(9). 1416–1422. 2 indexed citations
4.
Brügel, Mathias, Kocéila Amroun, Damien Botsen, et al.. (2024). Association between pancreatic adenocarcinoma risk and concentration of organochlorine pesticides in adipose tissue and urine: A targeted‐screening analysis case‐control study (PESTIPAC). United European Gastroenterology Journal. 12(7). 951–959. 5 indexed citations
5.
6.
Baudin, Éric, Christine Do Cao, Éric Dansin, et al.. (2023). Surgery of primary lung carcinoid tumors at metastatic stage: A national study from the French Group of Endocrine Tumors ( GTE ) and ENDOCAN‐RENATEN network. Journal of Neuroendocrinology. 35(10). e13331–e13331. 1 indexed citations
7.
Morland, David, Elizabeth Katherine Anna Triumbari, Marine Perrier, et al.. (2023). Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging. Clinical Nuclear Medicine. 48(6). 467–473. 3 indexed citations
8.
Brügel, Mathias, et al.. (2023). Prevalence of cannabidiol (CBD) consumption and cancer patients’ expectations in one oncology day-hospital: A cross-sectional study and questionnaire validation. Journal of Oncology Pharmacy Practice. 32(1). 3–13. 1 indexed citations
9.
Brügel, Mathias, Zoubir Djerada, Marine Perrier, et al.. (2023). Beta-blocker exposure and survival outcomes in patients with advanced pancreatic ductal adenocarcinoma: a retrospective cohort study (BETAPANC). Frontiers in Pharmacology. 14. 1137791–1137791. 5 indexed citations
10.
Perrier, Marine, Mathias Brügel, Bernard Goichot, et al.. (2023). Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network. European Journal of Endocrinology. 189(6). 575–583. 2 indexed citations
11.
Poncet, Gilles, et al.. (2022). Concept of reintervention with thorough lymphadenectomy after suboptimal resection of small‐intestine neuroendocrine neoplasms: A multicentre preliminary study. Journal of Neuroendocrinology. 34(6). e13117–e13117. 3 indexed citations
12.
Perrier, Marine, Olivia Hentic, Hédia Brixi, et al.. (2022). FOLFOX ‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors. Journal of Neuroendocrinology. 35(1). e13227–e13227. 8 indexed citations
13.
Perrier, Marine, Stéphanie Polazzi, Delphine Maucort‐Boulch, et al.. (2022). Healthcare cost by primary tumour, functioning status and treatment among patients with metastatic neuroendocrine tumours: The LyREMeNET study. Journal of Neuroendocrinology. 34(4). e13092–e13092. 3 indexed citations
14.
Botsen, Damien, Mathias Brügel, Éric Bertin, et al.. (2022). Association of Low Handgrip Strength with Chemotherapy Toxicity in Digestive Cancer Patients: A Comprehensive Observational Cohort Study (FIGHTDIGOTOX). Nutrients. 14(21). 4448–4448. 3 indexed citations
15.
16.
Berdah, Laura, Anne‐Sophie Romain, Aurélie Schnuriger, et al.. (2022). Retrospective observational study of the influence of the COVID-19 outbreak on infants’ hospitalisation for acute bronchiolitis. BMJ Open. 12(10). e059626–e059626. 8 indexed citations
17.
Walter, Thomas, Astrid Lièvre, David Malka, et al.. (2022). LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study. Annals of Oncology. 33. S1412–S1412. 5 indexed citations
18.
Triumbari, Elizabeth Katherine Anna, Hédia Brixi, Marine Perrier, et al.. (2022). Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors. Endocrine. 78(2). 380–386. 3 indexed citations
19.
Blinowska, Katarzyna J., et al.. (1990). Somatosensory evoked potentials from median nerve; normative data.. PubMed. 30(1). 35–9. 4 indexed citations
20.
Gherardi, Romain K., et al.. (1985). [Peripheral axonic neuropathy during treatment with almitrine bismesylate (Vectarion). Possible role of wasting].. PubMed. 5(6). 393–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan Hamilton Breakdown of academic impact, for papers by Russell P. Sawyer Breakdown of academic impact, for papers by George J. Francis Breakdown of academic impact, for papers by Tzu‐Ting Kuo Breakdown of academic impact, for papers by Gaofeng Pan Breakdown of academic impact, for papers by Sisi Dai Breakdown of academic impact, for papers by Mélissa Wills Breakdown of academic impact, for papers by Sabrina Pigozzo Breakdown of academic impact, for papers by Roland Backhaus
Rankless by CCL
2026